| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 52.5K | $1.69M | $32.30 | May 16, 2024 | Direct |
| Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | $87.9K | $5.86 | Jun 24, 2025 | Direct |
| SOLENO THERAPEUTICS INC | Director | Common Stock | 666 | $24.3K | $36.49 | Aug 26, 2022 | Direct |
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7.5K | $11.6K | $1.55 | Sep 3, 2025 | By Trust |
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15K | Sep 3, 2025 | Direct | ||
| SOLENO THERAPEUTICS INC | Director | Stock option (right to buy) | 10K | May 26, 2023 | Direct |